Nicole Negar Davarpanah - 10 Dec 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Chief Medical Officer
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
10 Dec 2025
Net transactions value
-$2,268,907
Form type
4
Filing time
12 Dec 2025, 19:37:03 UTC
Previous filing
15 Sep 2025
Next filing
29 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davarpanah Nicole Negar Chief Medical Officer 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO /s/ Shane Ward, Attorney-in-Fact 12 Dec 2025 0002067554

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Tax liability $2,268,907 -10,332 -33% $219.60 21,286 10 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for taxes on RSU vesting.
F2 Includes 200 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2025.